The most prevalent LRRK2 mutation, G2019S, has increased kinase activity and decreased GTPase activity, indicating that LRRK2 enzymatic activity may be linked to PD pathogenesis [21,22,23,24]. Here, LRRK2 is linked to Parkinson disease.